Navigation Links
89 North Wins Prestigious International Award
Date:2/6/2012

BURLINGTON, Vt., Feb. 6, 2012 /PRNewswire/ -- After only three years in business, 89 North won the prestigious 2011 Prism Award from the International Society for Optics and Photonics (SPIE) on Jan. 25. The award was for new products in the category of  "Life Sciences and Biophotonics."

The new product is 89 North's Heliophor, a patent-pending, innovative, high-intensity and exceptionally stable new light source used for quantitative fluorescence imaging in a wide variety of applications, including cancer research. A pumped-phosphor light engine, the Heliophor's stability and straightforward calibration system ensure that output intensity is consistent across measurements, allowing repeatable, truly quantitative fluorescent analysis.

The Prism Award was presented to 89 North at a gala banquet in San Francisco at SPIE's Photonics West Conference. SPIE gives the award "to products that challenge conventional ideas, solve problems, and improve life through the generation and harnessing of light."

SPIE was founded in 1955 to advance light-based technologies. Serving more than 180,000 constituents from 168 countries, the Society advances emerging technologies through interdisciplinary information exchange, continuing education, publications, patent precedent, and career and professional growth.

"The Heliophor provides a new alternative to arc lamps, metal halides, and LED light sources," SPIE said.

"The quality and competition among this year's entries was even keener than in past years," said SPIE CEO Eugene Arthurs. "More companies submitted applications than ever before. The strength of applications from core companies in our industry along with the impressive innovations bubbling up from smaller companies really demonstrates the vitality of the photonics industry."

89 North (www.89north.com), located in Burlington, Vermont, is a subsidiary of Bellow Falls' award-winning Chroma Technology Corp. (www.chroma.com). Chroma is a global employee-owned company manufacturing precision optical filters and coatings for biomedical instruments such as flow cytometers, plate readers and fluorescence microscopes.

"We created 89 North to encourage the kind of innovations that emerge when smart and creative people interact," said Chroma President Paul Millman. "The Prism award certifies the success of that interaction."

 

 


'/>"/>
SOURCE Chroma Technology Corp.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
2. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
3. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
4. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
5. Test for Life Commends North Carolina Rules Commission for Implementing CDC Recommendations for HIV Testing
6. MJFF and Merck Serono (EMD Serono in North America) Join Forces on $2-Million Initiative to Drive Treatments for PD-Related Cognitive Dysfunction and Mood Disorders
7. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
8. Northwestern Memorial Transplant Program Initiates New Study
9. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
10. Northwestern Memorial Study Tests Cancer Drug on Scleroderma Patients
11. Northern California Foot and Ankle Center Santa Rosa Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Research Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)...  Just 18 months after its February 2016 launch, ... the appointment of three new senior people to its ... Jones-Phillips and James Wright bring decades ... Tammy Wynne joins as Director, ... She has over ten years, experience in global market ...
(Date:8/31/2017)... PM360,s annual Innovations Issue, published in ... innovations happening across the industry. Established six years ago, ... providing a comprehensive look at the newest and most ... innovative companies, startups, divisions, products, services, and strategies from ... "Everyone in this industry wants to do better—in all ...
Breaking Medicine Technology:
(Date:9/20/2017)... , ... September 20, 2017 , ... Doctors on Liens ... their qualified network of medical professionals working on a personal injury lien basis. Founded ... Surgery Inc brings these esteemed doctors’ vast experience with orthopedic injuries to patients in ...
(Date:9/20/2017)... ... September 20, 2017 , ... Demand generation pioneer True ... edition of MarTech: The Marketing Tech Conference October 2–4, at the Hynes Convention ... speakers — representing such thought-leading companies as JP Morgan Chase, GE Digital, ...
(Date:9/20/2017)... ... September 20, 2017 , ... Compliancy Group is proud ... The Guard®, has helped another long-time client pass their Department of Health and ... the law. , Thanks to the help of the Compliancy Group's Audit Response ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... social campaign, “Humans With Vaginas.” The goal is to ignite conversation via social ... personal care products. The brand has declared September “Humans with Vaginas” month, releasing ...
(Date:9/20/2017)... ... September 20, 2017 , ... Medicare doesn’t ... risk of price gouging for their prescription drugs, according to a new comparison ... isn’t negotiating on our behalf, there’s no consistency in drug pricing among drug ...
Breaking Medicine News(10 mins):